Fiche centre
University Hospital Zurich
Zurich — Switzerland
Essais liés4clinical trials
VilleZurichlocalisation
PaysSwitzerlandlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04394546
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| FARAPULSE Pulsed Field Ablation System | Maladie coronarienne | À vérifier | NCT06808217 | OPALISE — A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation | ACTIVE_NOT_RECRUITING |
| WATCHMAN FLX LAAC Device | Accident vasculaire cérébral | Non applicable | NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |
| tDCS device from neuroConn | Migraine | NA | NCT03237754 | Neurostimulation in Chronic and Episodic Migraine | TERMINATED |